[1]
2026. IL-23 Inhibitors in Psoriasis: A Canadian Dermatology Roundtable. Actualité dermatologique au Canada. 7, s03 (sept. 2026), 2–9. DOI:https://doi.org/10.58931/cdt.2026.7s03166.